SCHEMBL2203083

SCHEMBL2203083

O=S(=O)(c1ccc(C(Cc2ccsc2)c2cc3cccnc3[nH]2)cc1)C1CC1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.46
NAMPT P43490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2195678 0.87 GCK (0.48) GCKNAMPT
SCHEMBL2196783 0.86 GCK (0.48) GCKNAMPT
SCHEMBL2196483 0.84 GCK (0.46) GCKNAMPT
SCHEMBL2347451 0.80 GCK (0.71) GCK
SCHEMBL2196267 0.79 GCK (0.70) GCK
SCHEMBL2195649 0.79 GCK (0.45) GCK
SCHEMBL2197921 0.78 GCK (0.71) GCK
SCHEMBL2195760 0.77 GCK (0.70) GCK
SCHEMBL2198311 0.72 GCK (0.60) GCK
SCHEMBL2196374 0.71 GCK (0.51) GCKNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011080755-A1 FUSED NITROGEN HETEROCYCLIC COMPOUNDS, PROCESS OF PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-07-07 WO claimed